Skip to main content
Log in

Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Shen ZX, Chen CQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY . Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients Blood 1997 89: 3354–3360

    CAS  PubMed  Google Scholar 

  2. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheineberg DA, Pandolfi PP, Warrel RP Jr . Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide N Engl J Med 1998 339: 1341–1348

    Article  CAS  PubMed  Google Scholar 

  3. Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, Stone RM, Kalycio M, Scheinberg DA, Steinherz P, Sievers EL, Coutrè S, Dahlberg S, Ellison R, Warrel RP . United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia J Clin Oncol 2001 19: 3852–3860

    Article  CAS  PubMed  Google Scholar 

  4. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pellicci PG, Biondi A, Lo Coco F . Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy Blood 1997 90: 1014–1021

    CAS  PubMed  Google Scholar 

  5. Lo Coco F, Diverio D, Avvisati G, Petti MC, Meloni G, Pogliani EM, Biondi A, Rossi G, Carlo-Stella C, Selleri C, Martini B, Specchia G, Mandelli F . Therapy of molecular relapse in acute promyelocytic leukemia Blood 1999 94: 2225–2229

    CAS  PubMed  Google Scholar 

  6. Delva L, Cornic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, Chomienne C . Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells Blood 1993 82: 2175–2181

    CAS  PubMed  Google Scholar 

  7. Chen GQ, Shi Xg, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z . Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells Blood 1997 89: 3345–3353

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tedeschi, A., Cairoli, R., Marenco, P. et al. Molecular remission and reconstitution of a full chimera with arsenic trioxide in a patient with acute promyelocytic leukemia relapsed after allogeneic bone marrow transplantation. Leukemia 16, 2455–2456 (2002). https://doi.org/10.1038/sj.leu.2402716

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402716

  • Springer Nature Limited

This article is cited by

Navigation